Patent · US Expired

2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists

US6489477B1 · kind B1 · utility

0Cited by
8References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 25, 2000
Grant dateDec 3, 2002
Priority date—
Expiry dateNov 12, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel 2-aza-bicyclo[2.2.2]octanes substituted in the 2-position are effective as NMDA NR2B antagonists useful for relieving pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.